Stroke patients resistant to the anti-platelet effects of aspirin are more likely to have severe strokes.

A study found 29% of patients were clinically resistant to aspirin. These patients scored higher on a stroke severity scale.

Aspirin resistance was shown to be more prevalent in smokers and those who had recently experienced a stroke.

Researchers recommended further study into alternative anti-platelet agents for aspirin-resistant patients.